A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder Article

Joshi, Gagan, Wozniak, Janet, Faraone, Stephen V et al. (2016). A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder . JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 36(3), 262-271. 10.1097/JCP.0000000000000499

International Collaboration

cited authors

  • Joshi, Gagan; Wozniak, Janet; Faraone, Stephen V; Fried, Ronna; Chan, James; Furtak, Stephannie; Grimsley, Emily; Conroy, Kristina; Kilcullen, J Ryan; Woodworth, K Yvonne; Biederman, Joseph

sustainable development goals

authors

publication date

  • June 1, 2016

published in

keywords

  • ASSOCIATION
  • CHILDREN
  • DOUBLE-BLIND
  • DYSFUNCTION
  • GENE
  • LINKAGE
  • Life Sciences & Biomedicine
  • PSYCHIATRIC COMORBIDITY
  • Pharmacology & Pharmacy
  • Psychiatry
  • RATING-SCALE
  • RELIABILITY
  • RISPERIDONE
  • Science & Technology
  • adults
  • autism spectrum disorder
  • memantine
  • psychopharmacology
  • treatment

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 262

end page

  • 271

volume

  • 36

issue

  • 3